PATENT CLAIM ANALYSIS

Application Number: 16065393
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "001650"]

Abstract:
The present invention is directed to novel non-invasive diagnostic took to dispose numerous disease states and/or conditions. The presets invention, represents a clear advance in the art which presently relies on tissue biopsy for diagnoses of these disease states. The novel imaging probe is capable of detecting infected cells, as well tissue. The methods described herein are able to diagnose, treat and/or monitor the therapy of numerous diseases and conditions including atherosclerosis, atherothrombosis, cerebral vascular disease, cerebral ischemia, cerebral infarct and meningitis as well as pneumonitis, pericarditis, multiple sclerosis, lupus erythematosus and pancreatitis, among others.

Claim (Index 29):
The method according to  claim 22  wherein said chelate group is 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA).

Metadata:
- Claim Count in Document: 51.0
- Percentile: 94.0
- Lexical Diversity: 1.52778
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13447918', '15261890', '12991253', '14093260', '13643412']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7378239314424926
- 35 USC 102 Novelty (BERT): 0.5107339494390293
- Combined Prediction Score: 0.7151149332421463
- Mean Citation Score: 244.28381200000004
- Max Citation Score: 247.1997
- Similarity Product: 152.81866400846243

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test